Growth Metrics

Collegium Pharmaceutical (COLL) Equity Ratio: 2016-2024

Historic Equity Ratio for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to 0.14.

  • Collegium Pharmaceutical's Equity Ratio rose 19.33% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 19.33%. This contributed to the annual value of 0.14 for FY2024, which is 19.53% down from last year.
  • As of FY2024, Collegium Pharmaceutical's Equity Ratio stood at 0.14, which was down 19.53% from 0.17 recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Equity Ratio registered a high of 0.29 during FY2021, and its lowest value of 0.14 during FY2024.
  • For the 3-year period, Collegium Pharmaceutical's Equity Ratio averaged around 0.16, with its median value being 0.17 (2022).
  • Per our database at Business Quant, Collegium Pharmaceutical's Equity Ratio crashed by 43.40% in 2022 and then climbed by 3.01% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Equity Ratio (Yearly) stood at 0.29 in 2020, then grew by 1.48% to 0.29 in 2021, then crashed by 43.40% to 0.17 in 2022, then increased by 3.01% to 0.17 in 2023, then decreased by 19.53% to 0.14 in 2024.